4/27/2020Growth of Chemical Drug Sales in Public Hospitals of Major Chinese Cit...

4/27/2020IQVIA: Chinese Online Drug B2C Market to Reach CNY 42.7B by 2023

4/27/2020NMPA and NHC Issue the 2020 GCP for Drug Clinical Trials

4/26/2020NMPA Issues the Biological Products Appendix of 2010 GMP

4/26/2020AkesoBio Launches $335M Hong Kong IPO

4/26/2020NHC Issues the Provisions for National Shortage Drug Lists (Interim)

4/25/2020Sanofi's China Sales Drops 14.4% in Q1/2020 Due to Volume-Based Procur...

4/25/2020Roche's NDA for SMA Drug Risdiplam Accepted by the NMPA

4/24/2020Health Awareness of Chinese Residents Rose to 19.17% in 2019

4/24/2020TRACON Seeks Licensing Partner for Prostate Cancer Drug TRC253 in Chin...

4/24/2020CNIPA: Early Resolution Mechanism for Drug Patent Disputes Shall Be Es...

4/24/2020Innovent and Eli Lilly Announce sNDA Acceptance for Sintilimab in Comb...

4/24/2020Gilead Disputes WHO Report That Remdisivir Failed in China Trial

4/23/2020CLINUVEL and Winhealth Pharma Enter Partnership Deal for EPP Drug

4/23/2020Menlo and Cutia Enter into Licensing Deal for AMZEEQ and Approved Topi...

4/23/2020SAMR Continues Focus on Pharma Sector Amid Covid-19 Outbreak, Fining A...

4/23/2020Henlius and Accord Receive Positive CHMP Opinion for Oncology Biosimil...

4/23/2020NPC to Review Several Public Health Related Bills

4/23/2020CStone's First Chinese NDA for Anticancer Avapritinib Accepted

4/23/2020Everest Med Approved for Clinical Trial of Sacituzumab in China

4/22/2020China Likely to Pull Some Drugs Out of the NRDL Soon

4/22/2020NMPA Publicizes List of Reference Formulations for Generic Drug Equiva...

4/22/2020Innovent Biologics Announces USFDA Approval of Pemazyre (Pemigatinib)

4/21/2020PwC: 2019 An Active Year in Chinese Pharma M&A

4/21/2020New Report: Cascading Economic Impacts of the COVID-19 Outbreak in Chi...

4/21/2020XiAn Janssen Launches Psoriasis Drug Tremfya (Geselkumab) in China

4/21/2020BeiGene's sNDA for Tislelizumab in Combo with NSCLC Chemotherapy in Ch...

4/21/2020Coronavirus Puts Big Pharma’s IP Regime to the Test

4/20/2020IQVIA: Chinese Retail Pharmacy Sales Up 3.9% in 2019

4/20/2020IQVIA: Urban Chinese Hospital Drug Market Up 9.4% in 2019

Page:185/719 Total number of articles:21568: [First][<<] [183] [184] [185] [186] [187] [>>] [End]